Home
PB Ratio of Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd
NSE: ASPIRAPATHLAB
PB Ratio
Key Highlights
- The latest PB Ratio of Aspira Pathlab & Diagnostics Ltd is 10.3.
- The PB ratio of the Aspira Pathlab & Diagnostics Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The P/B Ratio of Aspira Pathlab & Diagnostics Ltd changed from 6.1 on March 2024 to 12.1 on March 2025 . This represents a CAGR of 40.84% over 2 years.
Historical P/B Ratio of Aspira Pathlab & Diagnostics Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Aspira Pathlab & Diagnostics Ltd
Company Fundamentals for Aspira Pathlab & Diagnostics Ltd
Market Cap
74 Cr
EPS
2.3
P/E Ratio (TTM)
31.1
P/B Ratio (TTM)
10.3
Day’s High
73.23
Day’s Low
70.0
DTE
0.3
ROE
16.6
52 Week High
106.78
52 Week Low
50.49
ROCE
13.2
Market Price of Aspira Pathlab & Diagnostics Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 02 Dec 2025 | 72.43 |
| 01 Dec 2025 | 69.75 |
| 28 Nov 2025 | 66.43 |
| 27 Nov 2025 | 65.24 |
| 26 Nov 2025 | 64.29 |
| 25 Nov 2025 | 65 |
| 24 Nov 2025 | 64.6 |
| 21 Nov 2025 | 67.59 |
| 20 Nov 2025 | 66.94 |
| 19 Nov 2025 | 64.5 |
SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd
BlinkX Score for Aspira Pathlab & Diagnostics Ltd
Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Aspira Pathlab & Diagnostics Ltd | 10.3 | 74.55 |
| Max Healthcare Institute Ltd | 86.8 | 109347 |
| Apollo Hospitals Enterprise Ltd | 644.3 | 104782 |
| Fortis Healthcare Ltd | 122.4 | 68331 |
| Narayana Hrudayalaya Ltd | 113.9 | 39043 |
PB Ratio of Aspira Pathlab & Diagnostics Ltd Explained
₹74.55
Market cap
₹7
Book Value per Share
10.3X
PB Ratio
Historical Market Cap of Aspira Pathlab & Diagnostics Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Aspira Pathlab & Diagnostics Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Aspira Pathlab & Diagnostics Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Aspira Pathlab & Diagnostics Ltd News Hub
Aspira Pathlab & Diagnostics reports standalone net loss of Rs 0.02 crore in the June 2024 quarter
Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as
Read more
14 Aug 24
Aspira Pathlab & Diagnostics to announce Quarterly Result
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 13 Augu
Read more
05 Aug 24
Aspira Pathlab & Diagnostics AGM scheduled
Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the company will be
Read more
28 Aug 24
Aspira Pathlab & Diagnostics schedules board meeting
Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 Nove
Read more
30 Oct 24
